Dexamethasone potentiates IGF-I actions in porcine granulosa cells

Randall Urban, Y. H. Bodenburg, M. Nagamani, J. Peirce

Research output: Contribution to journalArticle

Abstract

To understand better interactions between glucocorticoids and insulin- like growth factor I (IGF-I) in the ovary, we studied the effects of dexamethasone on IGF-I stimulation of P-450 cholesterol side-chain cleavage enzyme (P-450(scc)) mRNA concentrations to porcine granulosa cells. Dexamethasone potentiated IGF-I-stimulated P-450(scc) mRNA concentrations and progesterone production in granulosa cell cultures. Time-course and dose- response studies showed that maximal enhancement occurred at a 1-μM dexamethasone concentration after 48 h of treatment. This potentiation was prevented by the glucocorticoid receptor antagonist RU-38486, 17β-hydroxy- 11β-[-4-dimethyl-aminophenyl]estra-4,9,-dien-3-one (RU-486). We investigated mechanisms for this potentiation by performing IGF-I binding studies in porcine granulosa cells. Dexamethasone increased IGF-I binding, and Scatchard analysis showed this enhanced binding was caused by an increase in receptor concentration. Northern blot hybridization using a rat type I IGF-I receptor gene riboprobe showed that although dexamethasone alone did not increase IGF- I receptor mRNA concentrations, it did prevent a decrease in receptor mRNA concentrations caused by IGF-I. In addition, we used synthetic primers from conserved regions of the rat type I IGF-I receptor gene with total RNA from porcine granulosa cells and polymerase chain reaction to isolate a 615-base pair porcine type I IGF-I receptor cDNA clone. Ribonuclease protection assay results were similar to those found with the rat IGF-I receptor riboprobe. We conclude that dexamethasone potentiates IGF-I actions on steroidogenesis in the porcine ovary. Possible mechanisms for this potentiation include the ability of dexamethasone to enhance IGF-I binding to porcine granulosa cells and prevent decreases in type I IGF-I receptor mRNA concentrations caused by IGF-I.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume267
Issue number1 30-1
StatePublished - 1994

Fingerprint

Granulosa Cells
Insulin-Like Growth Factor I
Dexamethasone
IGF Type 1 Receptor
Swine
Messenger RNA
Cholesterol Side-Chain Cleavage Enzyme
Rats
Mifepristone
Cytochrome P-450 Enzyme System
Ovary
Genes
Insulin, Regular, Pork
Polymerase chain reaction
Glucocorticoid Receptors
Ribonucleases
Cell culture
Base Pairing
Northern Blotting
Glucocorticoids

Keywords

  • P-450(scc)
  • RU-486
  • steroidogenesis

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Dexamethasone potentiates IGF-I actions in porcine granulosa cells. / Urban, Randall; Bodenburg, Y. H.; Nagamani, M.; Peirce, J.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 267, No. 1 30-1, 1994.

Research output: Contribution to journalArticle

@article{213cccf504924f94862e55e7e8b66da2,
title = "Dexamethasone potentiates IGF-I actions in porcine granulosa cells",
abstract = "To understand better interactions between glucocorticoids and insulin- like growth factor I (IGF-I) in the ovary, we studied the effects of dexamethasone on IGF-I stimulation of P-450 cholesterol side-chain cleavage enzyme (P-450(scc)) mRNA concentrations to porcine granulosa cells. Dexamethasone potentiated IGF-I-stimulated P-450(scc) mRNA concentrations and progesterone production in granulosa cell cultures. Time-course and dose- response studies showed that maximal enhancement occurred at a 1-μM dexamethasone concentration after 48 h of treatment. This potentiation was prevented by the glucocorticoid receptor antagonist RU-38486, 17β-hydroxy- 11β-[-4-dimethyl-aminophenyl]estra-4,9,-dien-3-one (RU-486). We investigated mechanisms for this potentiation by performing IGF-I binding studies in porcine granulosa cells. Dexamethasone increased IGF-I binding, and Scatchard analysis showed this enhanced binding was caused by an increase in receptor concentration. Northern blot hybridization using a rat type I IGF-I receptor gene riboprobe showed that although dexamethasone alone did not increase IGF- I receptor mRNA concentrations, it did prevent a decrease in receptor mRNA concentrations caused by IGF-I. In addition, we used synthetic primers from conserved regions of the rat type I IGF-I receptor gene with total RNA from porcine granulosa cells and polymerase chain reaction to isolate a 615-base pair porcine type I IGF-I receptor cDNA clone. Ribonuclease protection assay results were similar to those found with the rat IGF-I receptor riboprobe. We conclude that dexamethasone potentiates IGF-I actions on steroidogenesis in the porcine ovary. Possible mechanisms for this potentiation include the ability of dexamethasone to enhance IGF-I binding to porcine granulosa cells and prevent decreases in type I IGF-I receptor mRNA concentrations caused by IGF-I.",
keywords = "P-450(scc), RU-486, steroidogenesis",
author = "Randall Urban and Bodenburg, {Y. H.} and M. Nagamani and J. Peirce",
year = "1994",
language = "English (US)",
volume = "267",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "1 30-1",

}

TY - JOUR

T1 - Dexamethasone potentiates IGF-I actions in porcine granulosa cells

AU - Urban, Randall

AU - Bodenburg, Y. H.

AU - Nagamani, M.

AU - Peirce, J.

PY - 1994

Y1 - 1994

N2 - To understand better interactions between glucocorticoids and insulin- like growth factor I (IGF-I) in the ovary, we studied the effects of dexamethasone on IGF-I stimulation of P-450 cholesterol side-chain cleavage enzyme (P-450(scc)) mRNA concentrations to porcine granulosa cells. Dexamethasone potentiated IGF-I-stimulated P-450(scc) mRNA concentrations and progesterone production in granulosa cell cultures. Time-course and dose- response studies showed that maximal enhancement occurred at a 1-μM dexamethasone concentration after 48 h of treatment. This potentiation was prevented by the glucocorticoid receptor antagonist RU-38486, 17β-hydroxy- 11β-[-4-dimethyl-aminophenyl]estra-4,9,-dien-3-one (RU-486). We investigated mechanisms for this potentiation by performing IGF-I binding studies in porcine granulosa cells. Dexamethasone increased IGF-I binding, and Scatchard analysis showed this enhanced binding was caused by an increase in receptor concentration. Northern blot hybridization using a rat type I IGF-I receptor gene riboprobe showed that although dexamethasone alone did not increase IGF- I receptor mRNA concentrations, it did prevent a decrease in receptor mRNA concentrations caused by IGF-I. In addition, we used synthetic primers from conserved regions of the rat type I IGF-I receptor gene with total RNA from porcine granulosa cells and polymerase chain reaction to isolate a 615-base pair porcine type I IGF-I receptor cDNA clone. Ribonuclease protection assay results were similar to those found with the rat IGF-I receptor riboprobe. We conclude that dexamethasone potentiates IGF-I actions on steroidogenesis in the porcine ovary. Possible mechanisms for this potentiation include the ability of dexamethasone to enhance IGF-I binding to porcine granulosa cells and prevent decreases in type I IGF-I receptor mRNA concentrations caused by IGF-I.

AB - To understand better interactions between glucocorticoids and insulin- like growth factor I (IGF-I) in the ovary, we studied the effects of dexamethasone on IGF-I stimulation of P-450 cholesterol side-chain cleavage enzyme (P-450(scc)) mRNA concentrations to porcine granulosa cells. Dexamethasone potentiated IGF-I-stimulated P-450(scc) mRNA concentrations and progesterone production in granulosa cell cultures. Time-course and dose- response studies showed that maximal enhancement occurred at a 1-μM dexamethasone concentration after 48 h of treatment. This potentiation was prevented by the glucocorticoid receptor antagonist RU-38486, 17β-hydroxy- 11β-[-4-dimethyl-aminophenyl]estra-4,9,-dien-3-one (RU-486). We investigated mechanisms for this potentiation by performing IGF-I binding studies in porcine granulosa cells. Dexamethasone increased IGF-I binding, and Scatchard analysis showed this enhanced binding was caused by an increase in receptor concentration. Northern blot hybridization using a rat type I IGF-I receptor gene riboprobe showed that although dexamethasone alone did not increase IGF- I receptor mRNA concentrations, it did prevent a decrease in receptor mRNA concentrations caused by IGF-I. In addition, we used synthetic primers from conserved regions of the rat type I IGF-I receptor gene with total RNA from porcine granulosa cells and polymerase chain reaction to isolate a 615-base pair porcine type I IGF-I receptor cDNA clone. Ribonuclease protection assay results were similar to those found with the rat IGF-I receptor riboprobe. We conclude that dexamethasone potentiates IGF-I actions on steroidogenesis in the porcine ovary. Possible mechanisms for this potentiation include the ability of dexamethasone to enhance IGF-I binding to porcine granulosa cells and prevent decreases in type I IGF-I receptor mRNA concentrations caused by IGF-I.

KW - P-450(scc)

KW - RU-486

KW - steroidogenesis

UR - http://www.scopus.com/inward/record.url?scp=0028339671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028339671&partnerID=8YFLogxK

M3 - Article

C2 - 8048499

VL - 267

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 1 30-1

ER -